CD19 and neoplasm: LCEVs also carry tumor antigens and MHC I, and are loaded with tumor surface molecules, such as CD19, CD20, and CD22, which may participate in the important signaling pathways that are involved in cell-to-cell communication in LME [40] (Figure 3).